Silverback Therapeutics prices 11.5M-share IPO above range at $21

 

• Silverback Therapeutics (SBTX) has priced its IPO of 11.5M common shares at $21.00/share, for expected gross proceeds of $241.5M.
• Underwriters' over-allotment is an additional 1.725M shares.
• Trading kicks off December 4.
• Closing date is December 8.
• Previously: Silverback Therapeutics upsizes IPO, seeks to raise up to $200M (Dec. 3)
• https://seekingalpha.com/news/3641612-silverback-therapeutics-prices-11_5m-share-ipo-above-range-21